NEW YORK (GenomeWeb) – The New York Genome Center has named Harold Swerdlow its VP of Technology Innovation.

In the role, he will be responsible for developing technologies to be used in genomics research and in clinical applications, including microfluidic tools for reducing the cost of single-cell and other DNA preparation methods for next-generation sequencing.

Swerdlow formerly was head of R&D at the Wellcome Trust Sanger Institute, he formerly was chief technology officer at Dolomite, and he was senior director of research at Solexa.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.